Plain-English explanation
Battlefield innovation becomes fieldable capability through a disciplined transition: identify a technology against a real warfighter problem, vet it for maturity and manufacturability, demonstrate it against an operational gap, structure the IP (Intellectual Property) and export/import pathways, stand up trusted production, field it through a real acquisition pathway, and plan for sustainment. Skipping steps produces demonstrations, not capabilities.
The U.S. and allied acquisition system offers several routes for emerging capability — rapid commercial pathways like DIU (Defense Innovation Unit)’s Commercial Solutions Opening, small-business research programs (SBIR/STTR (Small Business Innovation Research)), other-transaction agreements, and SOF-specific channels. Each requires different evidence.
02 · Why it matters in UkraineWhy it matters in Ukraine
In Ukraine, capability is iterated under real operational pressure, sometimes weekly. That battlefield feedback is a design input. But a capability proven in Ukraine still has to be made trusted, compliant, and supportable before allied forces can rely on it.
03 · Why it matters to U.S. and allied warfightersWhy it matters to U.S. and allied warfighters
DIU’s CSO (Commercial Solutions Opening) process can award a prototype agreement in 60–90 days, and a successful prototype can transition to a follow-on production contract without re-competition. SBIR/STTR is often the entry point into the defense market. SOF (Special Operations Forces) channels like SOFWERX and USSOCOM’s acquisition authority offer fast paths for the most demanding environments.
04 · Why it matters to industry and manufacturingWhy it matters to industry and manufacturing
Understanding which pathway fits a given capability — and what evidence each requires — is the difference between an interesting demo and a funded program. Manufacturability and trusted sourcing have to be designed in from the start, not bolted on after award.
05 · Common misunderstandingsCommon misunderstandings
- “DIU gives grants.” DIU awards other-transaction prototype agreements (contracts), milestone-based — not grants.
- “Winning a prototype means guaranteed production funding.” A success memo enables follow-on production but does not guarantee it; a service partner must fund production.
- “SBIR is only for research, not products.” SBIR Phase III is explicitly about transitioning research to production.
Related technologies and concepts
This explainer ties together the Transition Model, trusted manufacturing, and the acquisition glossary terms (DIU, CDAO (Chief Digital and Artificial Intelligence Office), SBIR, STTR (Small Business Technology Transfer), SOF, OTA (Other Transaction Authority / Agreement), CSO).
07 · Further reading and videosFurther reading and videos
The DIU “Work With Us” page, SBIR.gov, the CDAO site, and SOFWERX are the core sources. No verified official-channel video was confirmed, so we link out.
08 · How Helicon works in this areaHow Helicon works in this area
This is exactly what Helicon does: the Transition Model is our disciplined path from battlefield feedback to fielded, sustainable capability — identify, vet, demonstrate, license, manufacture, field, sustain.
Key sources, explained
Each card explains why a source matters, what it teaches, and the Helicon takeaway. Public-domain primary texts can be read in full on this page; everything else links out.
Defense Innovation Unit (DIU)
MASK_10It is the clearest public explanation of the fastest commercial-to-DoD pathway.
That DIU uses a Commercial Solutions Opening to award Other Transaction prototype agreements in roughly 60-90 days, with a path to follow-on production — far faster than the traditional 12-24 month cycle.
Helicon structures transitions around real pathways like this one, choosing the route that fits the capability and the customer.
The Defense Innovation Unit’s Work With Us page is the clearest public explanation of one of the fastest commercial-to-Department-of-Defense pathways. DIU exists to bring proven commercial technology into military use quickly, and the mechanism it describes is distinctive. Rather than a traditional procurement, DIU issues a Commercial Solutions Opening — a problem statement inviting commercial solutions — and then awards Other Transaction (OT) prototype agreements to selected companies, typically in roughly 60 to 90 days. The OT authority sidesteps much of the Federal Acquisition Regulation overhead that slows conventional contracting, and a successful prototype carries a built-in path to follow-on production without a fresh full-and-open competition. The contrast that makes this matter is timeline: the traditional defense contracting cycle often runs 12 to 24 months before a company even begins work, long enough to exhaust a startup’s runway. By compressing that to weeks, DIU lowers the barrier for commercial and dual-use firms — including allied innovators — to engage the U.S. military. Helicon structures transitions around real pathways like this one, choosing the route that fits the maturity of the capability and the needs of the customer rather than forcing every technology through the same door.
Optional quick digest prepared by Helicon. The complete public-domain original is hosted here — use “Read full text” to read it in full on this site.
Defense Innovation Unit (DIU) — Work With Us
MASK_11It addresses the question every innovator asks: who owns the intellectual property.
That under DIU Other Transaction agreements, IP is generally retained by the company while the government receives a license or government-purpose rights — and a successful prototype can transition to follow-on production without re-competition.
Structuring IP, licensing, and export pathways early is part of Helicon’s transition discipline — handled with qualified professionals.
Intellectual property is the question every innovator asks before engaging the U.S. government, and DIU’s Other Transaction (OT) framework gives a reassuring answer. Under these agreements, IP is generally retained by the company; the government typically receives a license or government-purpose rights to use what it paid to develop, rather than taking full ownership of the underlying technology. That arrangement lets a firm keep commercializing its product in other markets while still supplying the Department of Defense. Equally important is the transition mechanism: a successful OT prototype can move directly into follow-on production without re-competing the work through a new full-and-open solicitation, which removes a notorious valley of death where promising prototypes die for lack of a contracting path. The practical lesson for innovators — and the discipline Helicon applies — is that IP ownership, licensing terms, and export posture (ITAR and EAR considerations, especially for allied technologies) should be structured deliberately at the very start of an engagement, with qualified legal and export counsel, not negotiated under time pressure once a deal is on the table. Getting the IP and export structure right early is what makes a clean, durable transition possible later.
Optional quick digest prepared by Helicon from the cited source. Open the original for the full text.
Cited sources
Every factual claim above traces to these sources, confirmed live as of the research date. Independently verify before operational use.
- Defense Innovation Unit — Work With Us MASK_23
- SBIR.gov — About MASK_24
- CDAO official website (ai.mil) MASK_25
- USSOCOM — SBIR MASK_26
- SOFWERX MASK_27
- Ukraine Recovery Conference 2026 — Official website MASK_28